For example, many different GBA1 mutations are associated with α-synucleinopathies, including putative null alleles [46, 47], and the molecular severity of a GBA1 allele correlates with the risk of developing an α-synucleinopathy in heterozygous carriers [48]. Here, GBA1 is linked to synucleinopathy.